1. Low expression of CRISP3 predicts a favorable prognosis in patients with mammary carcinoma
   Yanyan Wang et al, 2019, Journal of Cellular Physiology CrossRef
2. A Combined CRISP3 and SPINK1 Prognostic Grade in EPS-Urine and Establishment of Models to Predict Prognosis of Patients With Prostate Cancer
   Lizhu Chen et al, 2022, Frontiers in Medicine CrossRef
3. Retracted: Targeted Regulation of miR-26a on PTEN to Affect Proliferation and Apoptosis of Prostate Cancer Cells
   Weilu Li et al, 2019, Cancer Biotherapy and Radiopharmaceuticals CrossRef
4. Prostatın benign, prekürsör ve malign epitelyal proliferasyonlarında ERG ile PTEN ekspresyonlarının araştırılması ve bulguların klinikopatolojik korelasyonu
   Banu SARSIK KUMBARACI et al, 2022, Ege Tıp Dergisi CrossRef
5. MicroRNA-211 suppresses prostate cancer proliferation by targeting SPARC
   Peng Hao et al, 2018, Oncology Letters CrossRef
6. Androgen receptor mediated epigenetic regulation of CRISP3 promoter in prostate cancer cells
   Bhakti R. Pathak et al, 2018, The Journal of Steroid Biochemistry and Molecular Biology CrossRef
7. Comparison of cell cycle progression score with two immunohistochemical markers (PTEN and Ki-67) for predicting outcome in prostate cancer after radical prostatectomy
   Priscilla Léon et al, 2018, World Journal of Urology CrossRef
8. SPINKs in Tumors: Potential Therapeutic Targets
   Chengcheng Liao et al, 2022, Frontiers in Oncology CrossRef
9. LMTK2 as Potential Biomarker for Stratification between Clinically Insignificant and Clinically Significant Prostate Cancer
   Alvydas Vezelis et al, 2021, Journal of Oncology CrossRef
10. Phosphatidylinositol 3-kinase regulatory subunit 1 and phosphatase and tensin homolog as therapeutic targets in breast cancer
    Ebubekir Dirican et al, 2017, Tumor Biology CrossRef
11. LncRNA/miRNA/mRNA Network Introduces Novel Biomarkers in Prostate Cancer
    Mohammad Taheri et al, 2022, Cells CrossRef
12. Predictive value of combined analysis of pro‐NPY and ERG in localized prostate cancer
    Gitte Kristensen et al, 2018, APMIS CrossRef
13. Modern prostate cancer biomarkers. Prospects for EN2 in the prostate cancer diagnosis
    A. S. Tarabayeva et al, 2020, Cancer Urology CrossRef
14. Neoplasms of the Prostate
    David G. Bostwick et al, 2020, Urologic Surgical Pathology CrossRef
15. Cysteine-Rich Secretory Proteins (CRISP) are Key Players in Mammalian Fertilization and Fertility
    Soledad N. Gonzalez et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
16. Ethnicity and ERG frequency in prostate cancer
    Jason Sedarsky et al, 2018, Nature Reviews Urology CrossRef
17. Characterization of different oligomeric forms of CRISP2 in the perinuclear theca versus the fibrous tail structures of boar spermatozoa†
    M Zhang et al, 2021, Biology of Reproduction CrossRef
18. Clinical Utility and Biologic Implications of Phosphatase and Tensin Homolog (PTEN) and ETS-related Gene (ERG) in Prostate Cancer
    David Ullman et al, 2018, Urology CrossRef
19. Biomarker microRNAs for prostate cancer metastasis: screened with a network vulnerability analysis model
    Yuxin Lin et al, 2018, Journal of Translational Medicine CrossRef
20. Identification of a 4‐mRNA metastasis‐related prognostic signature for patients with breast cancer
    Xinhua Xie et al, 2019, Journal of Cellular and Molecular Medicine CrossRef
21. Prognostic implications of ERG, PTEN, and fatty acid synthase expression in localized prostate cancer
    Anan Fathi et al, 2018, Egyptian Journal of Pathology CrossRef
22. Exploring the role of differentially expressed metabolic genes and their mechanisms in bone metastatic prostate cancer
    Qingfu Zhang et al, 2023, PeerJ CrossRef